Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(amethopterin)
49,622 results
  • Combination Immunosuppression in IBD. [Journal Article]
  • IBInflamm Bowel Dis 2018 Feb 15; 24(3):539-545
  • Bots S, Gecse K, … D'Haens G
  • Whether to use biologic treatment for inflammatory bowel disease as monotherapy or in combination with immunosuppressives has been a matter of debate in the last 2 decades. Combination therapy was no...
  • [Juvenile idiopathic arthritis]. [Journal Article]
  • NTNed Tijdschr Tandheelkd 2018; 125(2):81-86
  • Schatorjé EJH, van Royen-Kerkhof A
  • Juvenile idiopathic arthritis (JIA) is the most common cause of chronic inflammation of the joints in childhood. Currently, JIA is divided into 7 subtypes, distinguished on the basis of the symptoms ...
  • Recent advances in the treatment of rheumatoid arthritis. [Journal Article]
  • COCurr Opin Rheumatol 2018 Feb 15
  • Mahajan TD, Mikuls TR
  • CONCLUSIONS: With the greatly expanded armamentarium of RA treatment options available, it is important for clinicians to understand the data regarding drug efficacy and safety. With remission increasingly attainable, effective drug tapering strategies are needed. Although tapering trials do exist, more studies will be needed to help guide clinical practice.
  • The Efficacy and Safety of Methotrexate versus Interferon in Cutaneous T-cell Lymphomas. [Journal Article]
  • JDJ Dermatolog Treat 2018 Feb 19; :1-22
  • Wain T, Pavli A, … Fernandez-Peñas P
  • CONCLUSIONS: The most significant finding of our study was that patients with cutaneous T cell lymphoma treated with IFN had a better response rate and significantly shorter response time compared with those treated with MTX. Additionally, patients had less disease progression on IFN than with MTX regardless of subtype of T cell lymphoma and stage of disease.
New Search Next